InfraScan

InfraScan receives 2022 Life Sciences PA Patient Impact Award InfraScan receives the Life Sciences PA Patient Impact Award for the second time. See more here

InfraScan Inc. Announces Publication of the Largest Study to date for TBI Diagnosis Utilizing NIRD Duke Global Neurosurgery and Neurology publishes its independent results from the largest U.S.-based study using a near-infrared device (NIRD) to detect hemorrhage due to Traumatic Brain Injuries (TBI). See more here

InfraScan announces FDA clearance of the first hand-held diagnostic device for Traumatic Brain Hemorrhage in children InfraScanner is now the only hand-held device cleared by the FDA to detect Traumatic Brain Hemorrhage in children See more here

InfraScan Inc. Announces DoD/DHA Product Development Partnership  InfraScan announces product development partnership with DoD See more here

Infrascan Inc. Announces Issuance of US Patents for Brain Diagnosis Latest patents expand near infrared platform capabilities related to trauma and stroke diagnosis    See more here

Infrascanner™ Brain Scanner Gets $3.7M-Expands head trauma detection capabilities Read more here

The Marine Corps Awards Contract for the Infrascanner™ Model 2000 Read more here

The U.S. Military's Miracle Scanner Read more here

InfraScan Receives FDA Approval of Next Generation, Noninvasive Handheld Brain Hematoma Detector Read more here

FDA Permits Marketing of the First Hand-held Device to Aid in the Detection of Bleeding in the Skull Read more here